Abingworth

Feb 03, 2021

Abingworth raises $465m for new life sciences fund Abingworth Bioventures 8

Dec 09, 2020

Reneo Pharmaceuticals Raises $95 Million in Series B Financing, Co-led by Novo Ventures and Abingworth

May 27, 2020

Q32 Bio Launches to Develop Novel Therapeutics Targeting Regulators of Innate and Adaptive Immunity

Nov 13, 2019

Abingworth Appoints Neil Cooper as Chief Financial Officer

Mar 26, 2019

Abingworth Appoints Bali Muralidhar as Partner

Oct 23, 2018

Abingworth Appoints Jackie Grant

Sep 21, 2018

Abingworth Appoints Brian Gallagher, Jr

Jul 09, 2018

Abingworth Raises $315m for ABV VII 12th Life Sciences Fund

Apr 30, 2018

Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough

Nov 06, 2017

NousCom Raises EUR42 Million Series B Financing